EFIB Pre-event webinar
Sustainability in industrial biotech innovations: life cycle assessment and beyond Get ready for EFIB 2021 by attending the kick-off webinar “Sustainability in Industrial biotech innovations: Life Cycle […]
Sustainability in industrial biotech innovations: life cycle assessment and beyond Get ready for EFIB 2021 by attending the kick-off webinar “Sustainability in Industrial biotech innovations: Life Cycle […]
The ‘EFIB 2021 Vienna Statement’ marked the launch of an annual call to action from EuropaBio members, with policy asks and actions critical in the short […]
Industrial Biotechnology for a sustainable society: a focus for 2023 and beyond Industrial biotechnology and biomanufacturing are recognised as being part of the response to some of […]
EuropaBio is pleased to announce that this year's edition of EFIB, Europe’s Leading Event on Industrial Biotechnology and the Bioeconomy under the title 'Industrial biotechnology for a sustainable and resilient global […]
Industrial biotechnology for a sustainable and resilient global Europe As the EU looks ahead to the European elections in 2024, with a new EU Commission mandate […]
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.